Have a personal or library account? Click to login
Onasemnogene Abeparvovec as New Gene Therapy in Patients with Spinal Muscular Atrophy – a Review of the Literature Cover

Onasemnogene Abeparvovec as New Gene Therapy in Patients with Spinal Muscular Atrophy – a Review of the Literature

Journal of Health Study and Medicine
Volume 2021 (2021): Issue 1 (March 2021)
By: Gabriela Ręka,  Angelika Pawlak and  Halina Piecewicz-Szczęsna  
Open Access
|Sep 2021

Authors

Gabriela Ręka

gabrysia.reka@gmail.com

Angelika Pawlak

Halina Piecewicz-Szczęsna

DOI: https://doi.org/10.36145/jhsm2021.05 | Journal eISSN: 2451-1471
Journal RSS Feed
Language: English
Page range: 85 - 100
Published on: Sep 22, 2021
Published by: SAN University
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
gene therapy,
spinal muscular atrophy
Related subjects:
Computer sciences,
Artificial intelligence,
Business and economics,
Business management,
Industries,
Health care,
Engineering,
Bioengineering and biomedical engineering,
Bionanotechnology,
Medicine,
Basic medical science,
Basic medical science, other

© 2021 Gabriela Ręka, Angelika Pawlak, Halina Piecewicz-Szczęsna, published by SAN University
This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 License.

Previous articleVolume 2021 (2021): Issue 1 (March 2021)Next article